A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,778 shares of VCYT stock, worth $119,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,778
Previous 2,282 21.74%
Holding current value
$119,315
Previous $49,000 91.84%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$21.0 - $35.25 $10,416 - $17,484
496 Added 21.74%
2,778 $94,000
Q2 2024

Jul 30, 2024

SELL
$18.86 - $23.55 $8.75 Million - $10.9 Million
-463,710 Reduced 99.51%
2,282 $49,000
Q1 2024

May 01, 2024

BUY
$21.0 - $29.1 $3.9 Million - $5.41 Million
185,930 Added 66.39%
465,992 $10.3 Million
Q4 2023

Jan 24, 2024

SELL
$19.72 - $28.68 $4.97 Million - $7.22 Million
-251,865 Reduced 47.35%
280,062 $7.7 Million
Q3 2023

Oct 26, 2023

BUY
$22.33 - $29.92 $391,444 - $524,497
17,530 Added 3.41%
531,927 $11.9 Million
Q2 2023

Aug 10, 2023

BUY
$20.96 - $26.99 $786,293 - $1.01 Million
37,514 Added 7.87%
514,397 $13.1 Million
Q1 2023

May 04, 2023

BUY
$20.58 - $27.89 $238,892 - $323,747
11,608 Added 2.49%
476,883 $10.6 Million
Q4 2022

Feb 09, 2023

SELL
$15.31 - $29.94 $2.01 Million - $3.93 Million
-131,336 Reduced 22.01%
465,275 $11 Million
Q3 2022

Nov 10, 2022

BUY
$16.58 - $27.9 $594,144 - $999,796
35,835 Added 6.39%
596,611 $9.9 Million
Q2 2022

Aug 15, 2022

BUY
$15.45 - $29.52 $3.78 Million - $7.22 Million
244,711 Added 77.42%
560,776 $11.2 Million
Q2 2022

Jul 26, 2022

SELL
$15.45 - $29.52 $1.93 Million - $3.68 Million
-124,717 Reduced 28.29%
316,065 $6.29 Million
Q1 2022

May 10, 2022

SELL
$21.94 - $42.51 $1.62 Million - $3.13 Million
-73,702 Reduced 14.33%
440,782 $12.2 Million
Q4 2021

Feb 08, 2022

SELL
$36.09 - $53.79 $1.84 Million - $2.75 Million
-51,046 Reduced 9.03%
514,484 $21.2 Million
Q3 2021

Nov 15, 2021

SELL
$35.62 - $52.97 $1.1 Million - $1.63 Million
-30,768 Reduced 5.16%
565,530 $26.3 Million
Q2 2021

Aug 11, 2021

BUY
$32.94 - $56.62 $19.6 Million - $33.8 Million
596,298 New
596,298 $23.8 Million
Q1 2021

May 13, 2021

SELL
$44.47 - $81.38 $14.7 Million - $27 Million
-331,579 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$32.49 - $61.88 $4.9 Million - $9.33 Million
150,836 Added 83.45%
331,579 $16.2 Million
Q3 2020

Nov 12, 2020

BUY
$26.73 - $35.67 $4 Million - $5.34 Million
149,823 Added 484.55%
180,743 $5.87 Million
Q2 2020

Aug 11, 2020

BUY
$19.49 - $28.11 $233,529 - $336,814
11,982 Added 63.27%
30,920 $801,000
Q1 2020

May 12, 2020

BUY
$16.13 - $30.17 $33,324 - $62,331
2,066 Added 12.25%
18,938 $461,000
Q4 2019

Feb 12, 2020

BUY
$20.78 - $29.99 $136,275 - $196,674
6,558 Added 63.58%
16,872 $471,000
Q3 2019

Nov 12, 2019

BUY
$23.87 - $30.93 $246,195 - $319,012
10,314 New
10,314 $247,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.07B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.